Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Context-Aware Multilevel Classification of Semantic Relations in Drug-Adverse Drug Reaction (ADR) Networks-Predicting Drug-Induced Liver Injury (DILI) as a Case Study.

Chemical research in toxicology·2026
Same author

Major ECG abnormalities and risk of incident cardiovascular disease in people with HIV compared to people without HIV.

AIDS (London, England)·2026
Same author

Aioli: Standardising Drugs in the FDA Adverse Event Reporting System (FAERS) to RxNorm and Anatomical Therapeutic Chemical (ATC) Codes.

Pharmacoepidemiology and drug safety·2025
Same author

Mapping between clinical and preclinical terminologies: eTRANSAFE's Rosetta stone approach.

Journal of biomedical semantics·2025
Same author

Sex-specific performance of electrocardiographic criteria for left ventricular hypertrophy in elite athletes.

Heart rhythm·2025
Same author

Using Structured Codes and Free-Text Notes to Measure Information Complementarity in Electronic Health Records: Feasibility and Validation Study.

Journal of medical Internet research·2025

Related Experiment Videos

Automatic detection of adverse events to predict drug label changes using text and data mining techniques.

Harsha Gurulingappa1, Luca Toldo, Abdul Mateen Rajput

  • 1Molecular Connections Pvt. Ltd., Bangalore, India.

Pharmacoepidemiology and Drug Safety
|August 13, 2013
PubMed
Summary

Automated text and open-source data mining can predict drug label changes. This pharmacovigilance approach identified previously undetectable adverse drug events, enhancing drug safety monitoring.

Keywords:
adverse eventmachine learningpharmacoepidemiologysignal detectiontext mining

Related Experiment Videos

Area of Science:

  • Pharmacovigilance
  • Text Mining
  • Data Science

Background:

  • Adverse drug events (ADEs) require continuous monitoring.
  • Traditional pharmacovigilance methods may miss emerging safety signals.
  • Integrating diverse data sources can improve ADE detection.

Purpose of the Study:

  • To evaluate the effectiveness of automated adverse event signal detection from text and open-source data.
  • To assess the impact of these signals on predicting drug label changes.

Main Methods:

  • Collected open-source adverse effect data from FAERS, Yellow Cards, and SIDER.
  • Employed a shallow linguistic relation extraction system (JSRE) for ADE extraction from MEDLINE case reports.
  • Utilized statistical methods for signal detection and prediction of label changes for 29 drugs.

Main Results:

  • Successfully predicted 76% of drug label changes automatically.
  • Identified 6% of drug label changes exclusively through text mining.
  • JSRE precisely identified four ADEs from MEDLINE that were previously undetectable.

Conclusions:

  • Automated prediction of drug label changes is feasible using data and text mining.
  • Text mining is a mature technology capable of supporting pharmacovigilance.
  • This approach enhances the ability to detect and respond to adverse drug events.